Evidence map›Paper›PMID 24736295›Full record

ArticleFamily practice2014

Placebo use in the UK: a qualitative study exploring GPs' views on placebo effects in clinical practice.

Felicity L Bishop, Jeremy Howick, Carl Heneghan, Sarah Stevens, F D Richard Hobbs, George Lewith

Open access · bronzeAbstract read
In one paragraph

Article in Family practice, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Harnessing placebo: Lessons from psychedelic science.Journal of psychopharmacology (Oxford, England) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Placebos Without Deception: Outcomes, Mechanisms, and Ethics.International review of neurobiology · 2018
    Review
  14. Review
  15. Context as a drug: some consequences of placebo research for primary care.Scandinavian journal of primary health care · 2016
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Felicity L BishopFaculty of Social and Human Sciences, Centre for Applications of Health Psychology, University of Southampton, Southampton, F.L.Bishop@southampton.ac.uk.
Jeremy HowickDepartment of Primary Care Health Sciences, University of Oxford, Oxford and.
Carl HeneghanDepartment of Primary Care Health Sciences, University of Oxford, Oxford and.
Sarah StevensDepartment of Primary Care Health Sciences, University of Oxford, Oxford and.
F D Richard HobbsDepartment of Primary Care Health Sciences, University of Oxford, Oxford and.
George LewithPrimary Care and Population Sciences, Faculty of Medicine, University of Southampton, Aldermoor Health Centre, Southampton, UK.
University of Oxford · GBUniversity of Southampton · GBPrimary Health Care · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurveys show GPs use placebos in clinical practice and reported prevalence rates vary widely.

aimTo explore GPs' perspectives on clinical uses of placebos. DESIGN AND

settingA web-based survey of 783 UK GPs' use of placebos in clinical practice.

methodsQualitative descriptive analysis of written responses ('comments') to three open-ended questions.

resultsComments were classified into three categories: (i) defining placebos and their effects in general practice; (ii) ethical, societal and regulatory issues faced by doctors and (iii) reasons why a doctor might use placebos and placebo effects in clinical practice. GPs typically defined placebos as lacking something, be that adverse or beneficial effects, known mechanism of action and/or scientific evidence. Some GPs defined placebos positively as having potential to benefit patients, primarily through psychological mechanisms. GPs described a broad array of possible harms and benefits of placebo prescribing, reflecting fundamental bioethical principles, at the level of the individual, the doctor-patient relationship, the National Health Service and society. While some GPs were adamant that there was no place for placebos in clinical practice, others focused on the clinically beneficial effects of placebos in primary care.

conclusionThis study has elucidated specific costs, benefits and ethical barriers to placebo use as perceived by a large sample of UK GPs. Stand-alone qualitative work would provide a more in-depth understanding of GPs' views. Continuing education and professional guidance could help GPs update and contextualize their understanding of placebos and their clinical effects.

Indexed as

Attitude of Health PersonnelGeneral PractitionersPlacebo EffectFemaleHumansMaleQualitative ResearchUnited KingdomAttitudesgeneral practicehealth knowledgeplacebo effectsplacebosqualitative research.

Identifiers

PMID24736295
PMCPMC5926436
OpenAlexW2098490888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.